Healthcare - Medical - Devices - NASDAQ - US
$ 5.95
-7.32 %
$ 766 M
Market Cap
-74.37
P/E
BALANCE SHEET
494 M
ASSETS
101 M
LIABILITIES
393 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Cytek Biosciences, Inc.
| Current Assets | 392 M |
| Cash & Short-Term Investments | 262 M |
| Receivables | 56.1 M |
| Other Current Assets | 73.5 M |
| Non-Current Assets | 102 M |
| Long-Term Investments | 1.6 M |
| PP&E | 29.3 M |
| Other Non-Current Assets | 71.5 M |
| Current Liabilities | 56.2 M |
| Accounts Payable | 3.03 M |
| Short-Term Debt | 3.01 M |
| Other Current Liabilities | 50.2 M |
| Non-Current Liabilities | 45.2 M |
| Long-Term Debt | 11.1 M |
| Other Non-Current Liabilities | 34 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 167.3 | 296.6 | 364.6 | 165.2 | 30.1 |
| Short Term Investments | 95.1 | 44.5 | 0 | 0 | 0 |
| Receivables | 56.1 | 48.9 | 29.8 | 18.1 | 17.7 |
| Inventory | 60.9 | 48.2 | 32.2 | 23.0 | 18.4 |
| Other Current Assets | 12.7 | 17.9 | 4.9 | 2.3 | 1.5 |
| Total Current Assets | 392.1 | 454.0 | 432.1 | 208.6 | 67.8 |
| PP&E | 29.3 | 27.6 | 5.9 | 2.1 | 1.0 |
| Intangible Assets | 23.1 | 4.3 | 4.7 | 0.3 | 0.3 |
| Goodwill | 16.2 | 10.1 | 10.1 | 0.5 | 0.5 |
| Long Term Investments | 1.6 | 1.6 | 0 | 0 | 0.2 |
| Other Long Term Assets | 1.8 | 1.4 | 1.7 | 1.1 | 63 K |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 494.5 | 519.5 | 463.7 | 220.0 | 70.4 |
| LIABILITIES | |||||
| Accounts Payable | 3.0 | 4.8 | 3.0 | 2.9 | 2.3 |
| Short Term Debt | 3.0 | 12.6 | 0 | 2.8 | 0 |
| Other Current Liabilities | 26.2 | 26.7 | 19.2 | 15.5 | 14.7 |
| Total Current Liabilities | 56.2 | 49.0 | 32.2 | 26.5 | 21.0 |
| Long Term Debt | 11.1 | 14.6 | 0 | 0 | 0 |
| Deferred Tax Income | 0 | 4.0 | 0.8 | 0.4 | 0.6 |
| Other Liabilities | 18.9 | 17.2 | 14.9 | 206.0 | 89.2 |
| Total Liabilities | 101.4 | 93.9 | 56.9 | 236.0 | 112.1 |
| EQUITY | |||||
| Common Stock | 0.1 | 0.1 | 0.1 | 23 K | 21 K |
| Retained Earnings | (29.2) | (17.0) | (18.2) | (22.6) | (42.0) |
| Other Accumulative Comprehensive Income/Loss | (1.3) | (0.7) | 0.9 | 65 K | (0.1) |
| Total Equity | 393.1 | 425.5 | 406.8 | (16.0) | (41.7) |
| Total Liabilities and Equity | 494.5 | 519.5 | 463.7 | 220.0 | 70.4 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 135.3 | 134.5 | 133.7 | 133.0 | 133.0 |